Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
RadNet, Inc. is a leading provider of outpatient diagnostic imaging services in the United States, operating primarily in the healthcare services and medical imaging industries. The company focuses on delivering high-quality, cost-effective imaging services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), X-ray, ultrasound, mammography, and related diagnostic procedures. RadNet generates the majority of its revenue through imaging services reimbursed by commercial insurers, Medicare, Medicaid, and other government programs.
Founded in 1981, RadNet evolved from a regional imaging provider into one of the largest outpatient diagnostic imaging networks in the country through organic growth and acquisitions. The company has positioned itself as a scaled operator with strong relationships with health systems, physician groups, and payors, leveraging centralized operations, standardized clinical protocols, and technology-enabled workflow management to drive efficiency and quality across its network.
Business Operations
RadNet operates through a network of outpatient imaging centers organized under regional business units, delivering diagnostic imaging services to referring physicians, hospitals, and patients. Its core revenue is generated from professional and technical fees associated with imaging exams performed at its facilities. The company operates predominantly in outpatient settings, which generally offer lower-cost alternatives to hospital-based imaging.
In addition to imaging services, RadNet has expanded into technology-enabled healthcare solutions through its Digital Health and Artificial Intelligence initiatives, including clinical workflow software and AI-driven imaging tools. The company also holds interests in imaging-related service businesses and collaborates with health systems through joint ventures, allowing RadNet to manage or co-own imaging centers while providing operational and administrative expertise.
Strategic Position & Investments
RadNet’s strategic direction emphasizes scale, operational efficiency, and technology-driven differentiation. Growth initiatives include selective acquisitions of independent imaging centers, expansion of joint venture partnerships with health systems, and continued investment in artificial intelligence to improve diagnostic accuracy and workflow efficiency. The company has made minority and majority investments in imaging AI and digital health platforms, reflecting its strategy to integrate advanced analytics into routine clinical practice.
Notable investments include RadNet’s involvement in AI-focused imaging companies and its internally developed technology platforms aimed at improving scheduling, patient engagement, and radiologist productivity. These efforts are intended to strengthen RadNet’s competitive position, enhance clinical outcomes, and create long-term value beyond traditional fee-for-service imaging.
Geographic Footprint
RadNet’s operations are concentrated in the United States, with a strong presence in major metropolitan markets. Key regions include California, New York, New Jersey, Maryland, Delaware, Pennsylvania, Florida, Texas, Arizona, and Nevada. The company’s headquarters are located in Los Angeles, California, which also represents its largest regional market.
While RadNet does not operate imaging centers outside the U.S., its influence extends internationally through technology investments and partnerships related to imaging artificial intelligence and digital health. These activities provide indirect international exposure without significant non-U.S. clinical operations.
Leadership & Governance
RadNet is led by a management team with long-standing experience in diagnostic imaging, healthcare operations, and technology-driven services. The leadership emphasizes disciplined capital allocation, strategic partnerships with health systems, and the integration of technology to enhance patient care and operational performance.
Key executives include:
- Howard G. Berger – President and Chief Executive Officer
- Mark Stolper – Executive Vice President and Chief Financial Officer
- Christopher Evensen – Executive Vice President and Chief Operating Officer
- Matthew Freije – Executive Vice President and Chief Development Officer
- Joshua H. Barback – Executive Vice President, General Counsel and Secretary
The company operates under a governance framework consistent with publicly traded healthcare services companies, with oversight provided by an independent board of directors and compliance with applicable U.S. healthcare and securities regulations.